Careers
Contact Us
Who We Are
Who We Are
Our History
Mission & Values
Our Team
Leadership
Board of Directors
Careers
ARCUS Genome Editing
Scientific Publications
ARCUS Platform
In Vivo Gene Editing
Pipeline
In Vivo
Gene Editing
Investors
Events & Presentations
Press Releases
Corporate Deck
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Sustainability
Investor FAQs
Partnering
Uncategorized
Uncategorized
Uncategorized
Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing
Read More
Uncategorized
Penn Announces Publication of Clinically Relevant Genome Editing in Primates Using Precision’s ARCUS Platform
Read More
Uncategorized
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
Read More
Uncategorized
Precision BioSciences CSO to Join Gene Therapy Session at DIA 2018
Read More
Uncategorized
Precision BioSciences to Present In Vivo Gene Therapy and Ex Vivo Cancer Immunotherapy Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Read More
1
2
